CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, today ...

CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc. today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s Zoom System, making it the first ...

September 14, 2012 — The US Food and Drug Administration (FDA) has approved a new catheter (Ascenda, Medtronic Inc) for use in the delivery of intrathecal baclofen (ITB) therapy. According to the ...

Following the FDA’s clearance earlier this year of its large-bore catheter for removing oxygen-blocking blood clots, Imperative Care is rolling out a new technique for treating stroke that combines ...

Route 92 Medical has announced that its HiPoint Reperfusion System, including the .088in HiPoint 88 aspiration catheter, has shown positive outcomes in the SUMMIT MAX trial compared to a conventional ...

Amid growing interest in interventional stroke treatments, some questions have recently emerged regarding the use of various catheters for aspiration thrombectomy that aren’t approved for that purpose ...

Intrathecal drug administration via lumbar puncture and a spinal access port device led to serious complications in a patient receiving experimental therapy for Niemann-Pick type C. In a case report ...

July 24, 2006 — The US Food and Drug Administration (FDA) and Medtronic, Inc, have warned healthcare professionals via letter regarding the worldwide voluntary recall of nonimplanted intrathecal ...

LOWELL, Mass., July 31, 2024 /PRNewswire/ -- Alcyone Therapeutics Inc. (Alcyone), a clinical-stage biotechnology company pioneering next-generation precision genetic therapies and precision delivery ...